|
Published by: Mintel International Group Ltd.
Published: Jun. 1, 2004 - 89 Pages
Table of Contents
INTRODUCTION AND ABBREVIATIONS
Introduction
Other Relevant Reports
Definition
Abbreviations & Terms
Abbreviations
Terms
EXECUTIVE SUMMARY
Baby boomers and seniors are major drivers for analgesics market
Babies and toddler formulations grow sales
Specific symptom pain relief could generate new customers
OTC vs. prescription drugs
Prevention may be the best medicine
Targeting a specific type of pain
Big gains in external analgesics market
Interest in alternative products
A $2.2 billion market
Delivery systems distinguish segments
Four big players and store brands account for most sales
McNeil is biggest spender on media
Drug stores edge out supermarkets for sales in 2003
Respondents are more likely to use extra strength products
Two thirds of respondents take pain killers for headaches
Drug stores and supermarkets favorite purchase sites
Future trends
Analgesics forecast to decline
MARKET DRIVERS
Aging population boosts market
Figure 1: U.S. population projections, 1998, 2003 and 2008
More products for children
Incidence of specific ailments
Figure 2: Prevalence of specific conditions/ailments among population aged 18 and older, by percent of population, 2001
OTC and prescription drug use
Figure 3: Usage of OTC vs. prescription drugs for specific ailments, January-September 2003
Prophylactic uses of analgesics
Analgesics targeting specific pain symptoms
Competition from other products
External analgesics
Alternative medicines
MARKET SIZE & TRENDS
Figure 4: Total U.S. retail sales of analgesic products, at current and constant prices, 1998-2003*
Graph 1: Total U.S. retail sales of internal analgesic products, at current and constant prices, 1998-2003*
MARKET SEGMENTATION
Figure 5: Sales of analgesics, segmented by delivery system, 2001 and 2003*
Analgesic tablets
Figure 6: Sales of analgesic tablets, at current and constant prices, 1998-2003*
Analgesic liquids
Figure 7: Sales of analgesic liquids, at current and constant prices, 1998-2003*
SUPPLY STRUCTURE
COMPANIES AND BRANDS
Figure 8: Manufacturer sales of internal analgesic products in the U.S., 2001 & 2003*
Analgesic tablets
Figure 9: Manufacturer brand sales of internal analgesic tablets in the U.S., 2001 and 2003*
Analgesic liquids
Figure 10: Manufacturer brand sales of internal analgesic liquids in the U.S., 2001 & 2003*
Profiles of Major Manufacturers
McNeil Consumer Products (Johnson & Johnson)
Wyeth
Bayer Consumer Health Division International
Bristol Myers-Squibb
ADVERTISING & PROMOTION
McNeil Consumer Products
Bayer Consumer Health Division International
Bristol Myers-Squibb
Wyeth
RETAIL DISTRIBUTION
Introduction
Figure 11: U.S. retail sales of internal analgesic products, by channel, 2001 and 2003*
Drug stores
Figure 12: U.S. drug store sales of internal analgesics, at current and constant prices, 1998-2003
Drug store operating data
Figure 13: Top drug store operating statistics, latest fiscal year-end
Figure 14: Percentage change from latest fiscal year-end versus year prior
Supermarkets
Figure 15: U.S. supermarket sales of internal analgesics, at current and constant prices, 1998-2003
Supermarket operating data
Figure 16: Top supermarket operating statistics, latest fiscal year-end
Figure 17: Percentage change from latest fiscal year-end versus year prior
THE CONSUMER
Introduction
Usage of analgesics
Figure 18: Usage of OTC analgesics, January 2003-September 2003
Figure 19: Usage of OTC analgesics, by gender, January 2003-September 2003
Figure 20: Usage of OTC analgesics, by age, January 2003-September 2003
Figure 21: Usage of OTC analgesics, by race/ethnicity, January 2003-September 2003
Types of analgesics used
Figure 22: Types of analgesics used, January 2003-September 2003
Figure 23: Types of analgesics used, by age, January 2003-September 2003
Figure 24: Types of analgesics used, by race/ethnicity, January 2003-September 2003
Forms of analgesics used
Figure 25: Forms of analgesics used, January 2003-September 2003
Figure 26: Forms of analgesics used, by age, January 2003-September 2003
Figure 27: Forms of analgesics used, by race/ethnicity, January 2003-September 2003
Reasons for using OTC analgesics
Figure 28: Ailments for which OTC analgesics are used, January 2003-September 2003
Figure 29: Ailments for which OTC analgesics are used, by gender, January 2003-September 2003
Figure 30: Ailments for which OTC analgesics are used, by age, January 2003-September 2003
Figure 31: Ailments for which OTC analgesics are used, by race/ethnicity, January 2003-September 2003
Purchase venues for OTC analgesics
Figure 32: Purchase venues for OTC pain relievers, May 2004
Figure 33: Purchase venues for OTC pain relievers, by age, May 2004
Figure 34: Purchase venues for OTC pain relievers, by household income, November 2000
Figure 35: Purchase venues for OTC pain relievers, by race/ethnicity, November 2000
Interest in new forms of analgesics
Figure 36: Interest in new forms of pain relievers, May 2004
Figure 37: Interest in new forms of pain relievers, by age, May 2004
Figure 38: Interest in new forms of pain relievers, by household income, May 2004
Attitudes and opinions concerning analgesics
Figure 39: Attitudes towards analgesics, May 2004
Figure 40: Attitudes towards analgesics, by age, May 2004
Analgesics and health issues
Figure 41: Knowledge of potential risk of mixing acetominophen and alcohol, May 2004
Figure 42: Knowledge of potential risk of mixing acetominophen and alcohol, by age, May 2004
Opinions concerning OTC and prescription medications
Figure 43: Attitudes towards OTC vs. prescription medications, January 2003-September 2003
Figure 44: Attitudes towards OTC vs. prescription medications, by age, January 2003-September 2003
Figure 45: Attitudes towards OTC vs. prescription medications, by race/ethnicity, January 2003-September 2003
Summary
FUTURE & FORECAST
FUTURE TRENDS
Aging population will help drive sales
Interest in children's products will also continue
Specific ailments require specific treatments
Prophylactic usage of analgesics may drive market
Competition
MARKET FORECAST
Analgesics
Figure 46: Forecast of total U.S. retail sales of analgesic products, at current and constant prices, 2003-2008
Graph 2: Sales of analgesics at current prices, 1998-2008
Analgesic Tablets
Figure 47: Forecast of U.S. sales of analgesic tablets, at current and constant prices, 2003-2008
Analgesic Liquids
Figure 48: Forecast of U.S. sales of analgesic liquids, at current and constant prices, 2003-2008
Forecast Factors
APPENDIX: TRADE ASSOCIATIONS
APPENDIX: NEW PRODUCT BRIEFS
Chattem: Pamprin All Day Maximum Strength Pain Reliever
McNeil Consumer Products: Tylenol Extra Strength Cool Caplets
McNeil Consumer Products: Tylenol Arthritis Pain Extended Pain Relief
Bayer: Bayer Children's Genuine Aspirin Chewable Tablets
Bayer: Bayer Safety Coated Aspirin
Bayer: Bayer Mint Flavor Chewable Aspirin
Bayer: Bayer Women's Aspirin
Bristol Myers-Squibb: Excedrin Tension Headache
APPENDIX: RESEARCH METHODOLOGY
Consumer Research
Sampling & Weighting
Presentation & Definition
Further Analysis
Trade Research
Informal trade research
Formal trade research
Desk & Internet Research
Sources
Definitions
Forecasts
APPENDIX: WHAT IS MINTEL?
Mintel Publications
Mintel Services
Product retrieval
Retail audits
Tailored research
Global New Products Database
Research Support/Consultancy/MIC
The Mintel Information Centre (MiC)
PR Research
AbstractBaby Boomers and older consumers are two main purchasers of analgesic products, both for pain relief and for protection against a number of ailments. Boomers are an especially ripe market as they represent a large percentage of the population and one that is aging and active. As Boomers age, their predisposition to arthritis will increase; they will continue their active lifestyles but they will be more likely to look for pain relief. Boomers and older consumers will also look to analgesics for prophylactic uses-to prevent heart attacks and strokes, for example. Research into the uses of analgesics as preventative measures against a number of diseases continues to provide more opportunities for manufacturers.
Get Full Details About This Report >>
|
